🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the manufacturers of acetaminophen, claiming the companies hid alleged dangers that the drug created to children's neurological development.

This legal action follows thirty days after President Donald Trump advocated an unverified association between using Tylenol - referred to as acetaminophen - during pregnancy and autism spectrum disorder in children.

Paxton is taking legal action against Johnson & Johnson, which previously sold the medication, the only pain reliever recommended for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he stated they "misled consumers by making money from discomfort and pushing pills regardless of the dangers."

Kenvue states there is no credible evidence connecting Tylenol to autism.

"These manufacturers lied for decades, knowingly endangering countless individuals to boost earnings," Paxton, from the Republican party, declared.

The company stated officially that it was "seriously troubled by the dissemination of inaccurate information on the safety of acetaminophen and the possible consequences that could have on the health of US mothers and children."

On its online platform, Kenvue also said it had "consistently assessed the relevant science and there is insufficient valid information that indicates a established connection between using paracetamol and autism spectrum disorder."

Associations acting on behalf of medical professionals and healthcare providers concur.

The American College of Obstetricians and Gynecologists has said paracetamol - the primary component in acetaminophen - is a restricted selection for pregnant women to manage discomfort and fever, which can create serious health risks if not addressed.

"In over twenty years of studies on the use of paracetamol in gestation, not a single reputable study has successfully concluded that the consumption of acetaminophen in any stage of gestation leads to neurological conditions in young ones," the group stated.

The court filing references latest statements from the previous government in claiming the medication is potentially dangerous.

Recently, the former president caused concern from public health officials when he instructed women during pregnancy to "struggle intensely" not to use Tylenol when unwell.

Federal regulators then published an announcement that physicians should think about restricting the consumption of acetaminophen, while also declaring that "a direct connection" between the medication and autism in children has not been established.

The Health Department head Kennedy, who manages the FDA, had pledged in April to undertake "a massive testing and research effort" that would identify the source of autism spectrum disorder in a short period.

But authorities cautioned that discovering a unique factor of autism - considered by experts to be the outcome of a complex mix of genetic and surrounding conditions - would not be simple.

Autism is a category of permanent neurological difference and disability that influences how individuals experience and engage with the environment, and is diagnosed using doctors' observations.

In his legal document, Paxton - who supports Trump who is seeking US Senate - asserts Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the research" around acetaminophen and autism spectrum disorder.

This legal action seeks to make the corporations "destroy any commercial messaging" that claims acetaminophen is reliable for expectant mothers.

The court case mirrors the complaints of a assembly of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who sued the makers of acetaminophen in 2022.

Judicial authorities rejected the legal action, saying research from the plaintiffs' authorities was inconclusive.